
Rohto Pharmaceutical Co.,Ltd.
4527.TJPXConsumer DefensiveHousehold & Personal Products
Latest quote
¥2,930.5
+¥64.00 · +2.23%
4527.T company overview
Regular session · JST · Market data may be delayed.
Company profile
Company websiteEstablished in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- Headquarters
- JP
- CEO
- Kunio Yamada
- Listed since
- Jan 4, 2001
- Employees
- 9,292
Market position
- Volume
- 742K
- 0.71× average
- Average volume
- 1.04M
- Average daily volume
- Market cap
- 662.19B JPY
- Beta
- -0.46
- Market reference 1
Financials
Financial snapshot
Latest / TTMFinancial health
- Altman Z-score
- 4.55
- Piotroski F-score
- 4 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 343.73B JPY | 308.63B JPY | 270.84B JPY | 238.66B JPY | 199.65B JPY |
| Cost of goods sold | 160.77B JPY | 139.16B JPY | 115.91B JPY | 103.53B JPY | 85.55B JPY |
| Gross profit | 182.96B JPY | 169.46B JPY | 154.93B JPY | 135.13B JPY | 114.1B JPY |
| Research and development | 13.73B JPY | 15B JPY | 13.46B JPY | 11.12B JPY | 8.78B JPY |
| Selling, general, and administrative | 128.52B JPY | 116B JPY | 101.31B JPY | 90.48B JPY | 77.46B JPY |
| Operating expenses | 142.25B JPY | 131B JPY | 114.77B JPY | 101.59B JPY | 86.24B JPY |
| Interest income | 1.13B JPY | 1.22B JPY | 1.52B JPY | 962M JPY | 368M JPY |
| Interest expense | 1.28B JPY | 949M JPY | 196M JPY | 247M JPY | 248M JPY |
| Depreciation and amortization | 17.38B JPY | 13.14B JPY | 8.69B JPY | 7.8B JPY | 7.69B JPY |
| Operating income | 40.71B JPY | 38.47B JPY | 40.17B JPY | 33.54B JPY | 27.86B JPY |
| Net income | 34.25B JPY | 31.01B JPY | 30.94B JPY | 26.38B JPY | 21.13B JPY |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 55%
- 6 beats, 5 misses, 0 met estimates
- Average EPS surprise
- +7.95%
- 11 comparable reports
- Latest EPS result
- 47.14
- Estimate 38.77 · Beat by 21.59%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
¥41.00
2025 complete year+182.8% since 2021
2026 partial: ¥25.00
¥14.50
2,021
¥20.50
2,022
¥24.00
2,023
¥31.00
2,024
¥41.00
2,025
¥25.00
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥25.00Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 30, 2027 | ¥25.00Semi-Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥25.00Semi-Annual | Mar 31, 2026 | Jun 8, 2026 |
Dividend | Sep 29, 2025 | ¥21.00Semi-Annual | Sep 30, 2025 | Dec 4, 2025 |
Dividend | Mar 28, 2025 | ¥20.00Semi-Annual | Mar 31, 2025 | Jun 12, 2025 |
Dividend | Sep 27, 2024 | ¥16.00Semi-Annual | Sep 30, 2024 | Dec 5, 2024 |
Ex-dividend Sep 29, 2026
¥25.00
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2027
¥25.00
Semi-Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥25.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 8, 2026
Ex-dividend Sep 29, 2025
¥21.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 4, 2025
Ex-dividend Mar 28, 2025
¥20.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 12, 2025
Ex-dividend Sep 27, 2024
¥16.00
Semi-Annual
Record Sep 30, 2024 · Payment Dec 5, 2024
4527.T peers
ETFs holding 4527.T
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T1.55B0.05%2.89T JPY0.05%¥418.5+0.12%
iShares JPX-Nikkei 400 ETF1364.T454.91M0.08%592.34B JPY0.05%¥3,765+0.11%
Vanguard Total International Stock ETFVXUS45.04M0.01%646.2B USD0.05%$87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA30.01M0.01%315B USD0.03%$73.42+0.80%
iShares Core MSCI EAFE ETFIEFA25.09M0.01%195.14B USD0.07%$100.85+0.86%
iShares MSCI EAFE Small-Cap ETFSCZ11.8M0.09%13.28B USD0.40%$86.60+0.70%
Schwab International Equity ETFSCHF8M0.01%69.7B USD0.03%$28.46+0.85%
Vanguard FTSE All-World ex-US ETFVEU7.12M0.01%95.9B USD0.04%$85.69+0.82%
iShares Core TOPIX ETF1475.T- Market value
- 1.55B
- Weight
- 0.05%
- AUM
- 2.89T JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥418.5+0.12%
iShares JPX-Nikkei 400 ETF1364.T- Market value
- 454.91M
- Weight
- 0.08%
- AUM
- 592.34B JPY
- Expense ratio
- 0.05%
- Price / 1D
- ¥3,765+0.11%
Vanguard Total International Stock ETFVXUS- Market value
- 45.04M
- Weight
- 0.01%
- AUM
- 646.2B USD
- Expense ratio
- 0.05%
- Price / 1D
- $87.71+0.78%
Vanguard FTSE Developed Markets ETFVEA- Market value
- 30.01M
- Weight
- 0.01%
- AUM
- 315B USD
- Expense ratio
- 0.03%
- Price / 1D
- $73.42+0.80%
iShares Core MSCI EAFE ETFIEFA- Market value
- 25.09M
- Weight
- 0.01%
- AUM
- 195.14B USD
- Expense ratio
- 0.07%
- Price / 1D
- $100.85+0.86%
iShares MSCI EAFE Small-Cap ETFSCZ- Market value
- 11.8M
- Weight
- 0.09%
- AUM
- 13.28B USD
- Expense ratio
- 0.40%
- Price / 1D
- $86.60+0.70%
Schwab International Equity ETFSCHF- Market value
- 8M
- Weight
- 0.01%
- AUM
- 69.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $28.46+0.85%
Vanguard FTSE All-World ex-US ETFVEU- Market value
- 7.12M
- Weight
- 0.01%
- AUM
- 95.9B USD
- Expense ratio
- 0.04%
- Price / 1D
- $85.69+0.82%
Continue in GoAI
Research 4527.Tresearch.disclaimer





